CEOI MEMBER SINCE 2023

Mick Farrell was appointed ResMed’s CEO and has served as a director since March 2013. In January 2023, he was appointed chair of the company’s board of directors. He joined the company in 2000, serving as president of the Americas region from 2011 to 2013, senior vice president of the global sleep apnea business unit from 2007 to 2011, and various senior roles in marketing and business development. Before joining ResMed, Mr. Farrell worked in management consulting, biotechnology, chemicals, and metals manufacturing at companies including Arthur D. Little, Sanofi Genzyme, Dow Chemical, and BHP. He serves on the board of directors of ResMed, the Advanced Medical Technology Association (AdvaMed), and Zimmer Biomet, a multibillion-dollar public company that provides implantable musculoskeletal medical devices for patients globally. He is also a member of two committees at Zimmer Biomet: the compensation and management development committee, as well as the quality, regulatory & technology committee, where he also serves as chair. He volunteers as a trustee for nonprofit organizations: UC San Diego Foundation, Rady Children’s Hospital, and Father Joe’s Villages’ project for the homeless in San Diego, California. Mr. Farrell holds a bachelor of engineering degree, with first-class honors, from the University of New South Wales, an MS degree in chemical engineering from the Massachusetts Institute of Technology, and an MBA from the MIT Sloan School of Management.